ReviewDrugs & aging2018
Medication-Induced Xerostomia and Hyposalivation in the Elderly: Culprits, Complications, and Management.
Review in Drugs & aging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06201923 (The Efficacy of Thyme Honey Mouth Rinse on Polypharmacy-induced Xerostomia), which is not on this map. Cited by 76 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Efficacy of Thyme Honey Mouth Rinse on Polypharmacy-induced Xerostomia (A Randomized Controlled Clinical Trial With a Biochemical Assessment)
Who cites it
76 citing papers in PubMed, 3 syntheses or guidelines pooled it, 197 citations in OpenAlex.
- Prevalence of xerostomia and hyposalivation in older adults: a systematic review and meta-analysis.BMC oral health · 2026Pooled it
- Association between medication-induced xerostomia and orofacial pain: a systematic review.Quintessence international (Berlin, Germany : 1985) · 2023Pooled it
- Association between anticholinergic activity and xerostomia and/ or xerophthalmia in the elderly: systematic review.BMC pharmacology & toxicology · 2022Pooled it
- Efficacy of adhesive discs for nocturnal xerostomia after head and neck radiotherapy: a randomized crossover trial.Clinical oral investigations · 2026Trial
- Efficacy of an oral hygiene intervention on a geriatric ward: from sample size calculation to dropout-driven disillusionment - a randomised controlled study.BMC oral health · 2025Trial
- Barriers, challenges, and facilitators in oral health care for older adults in home-based care: stakeholder perspectives from germany.BMC geriatrics · 2026Article
- Salivary flow measurements in a clinical setting: the Dutch consensus statement.Clinical oral investigations · 2026Article
- Stimulated whole salivary flow is correlated with xerostomia severity and unstimulated whole salivary flow in adults with xerostomia taking anticholinergic medications.Archives of oral biology · 2026Article
- Assessment of Dry Mouth in a Palliative Population: A Comparison Between Patient-Reported Symptoms and Clinical Oral Dryness Scale Measurements.The American journal of hospice & palliative care · 2026Article
- Mucoadhesive Gel Based onPharmaceutics · 2026Article
- Compressed Medicated Chewing Gum with Lysozyme Hydrochloride and Ascorbic Acid for Xerostomia Relief and Oral Health Support: Formulation Development, Optimization,Pharmaceutics · 2026Article
- Polypharmacy, salivary function, and oral health outcomes in institutionalized older adults: A scoping review.Journal of clinical and experimental dentistry · 2026Review
- Knowledge, attitude, and practice of dentists in India regarding geriatric oral healthcare and polypharmacy management: a cross-sectional study.BMC geriatrics · 2026Article
- Minor salivary flow as a diagnostic tool for screening hyposalivation in Medication-Induced Xerostomia.BMC oral health · 2026Article
- Oral Side Effects of the Most Commonly Prescribed Drugs in Germany.Dentistry journal · 2026Article
- Medication-Induced Xerostomia: Cross-Sectional Analysis of Salivary Flow, Intraoral Aching, and Anxiety.Journal of clinical medicine · 2025Article
- Oral Health in Individuals with Severe Mental Illness on Second-Generation Antipsychotics-A Scoping Review.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2025Article
- The economic and societal impact of periodontal and peri-implant diseases.Periodontology 2000 · 2025Review
- Medication Purchases Are Associated With the Number of Dental Treatments.Clinical and experimental dental research · 2025Article
- Association Between Multimorbidity and Root Caries Among Older American Adults.Dentistry journal · 2025Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medication-induced xerostomia and hyposalivation will increasingly become oral health issues for older and geriatric patients because of the likely high prevalence of medication intake and polypharmacy, with a complex negative impact on other symptoms such as dysphagia, caries incidence, malnutrition, and quality of life. All healthcare professionals are encouraged to investigate dry mouth symptoms among their patients, since diagnosis can easily be performed within daily clinical practice. This practical article also provides a review of available treatment options, which include medication changes towards products with fewer xerogenic side effects or dose reductions, if possible, as well as multidisciplinary, preventive care-oriented approaches that consider all influencing factors and treatment of the oral symptoms. In addition, several topical agents and saliva substitutes are discussed that may provide symptomatic relief but need to be carefully adapted to each patient's situation in terms of usability and practicability and in the knowledge that therapeutic success varies with each individual. Innovative methods such as intraoral electrostimulation or topical application of anticholinesterase on the oral mucosa are also discussed. The most commonly prescribed pharmaceutical treatment options for dry mouth are pilocarpine (a parasympathomimetic agent with potent muscarinic, cholinergic salivation-stimulating properties) and cevimeline (a quinuclidine analogue with therapeutic and side effects similar to those of pilocarpine). These pharmaceutic treatment options are described in the context of older patients, where the highly prevalent cholinergic side effects, which include nausea, emesis, bronchoconstriction, among others, need to be thoroughly supervised by the healthcare professionals involved. Providing these therapeutic options to patients with medication-induced dry mouth will help improve their oral health and therefore maintain a better quality of life, general health, and well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.